Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssetco Regulatory News (ASTO)

  • There is currently no data for ASTO

Schedule One - AssetCo Plc

31 Mar 2021 11:30

RNS Number : 1329U
AIM
31 March 2021
 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

AssetCo plc

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

Singleton Court Business Park

Wonastow Road

Monmouth

Monmouthshire

NP25 5JA

 

COUNTRY OF INCORPORATION:

England and Wales

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

www.assetco.com

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

On 8 February 2021, the Board announced its intention to change the business strategy of the Company to the development of an asset and wealth management business (the "New Strategy"). The proposed New Strategy will result in a fundamental change of business and the Company will effect a readmission of its Ordinary Shares pursuant to AIM Rule 14.

 

Upon completion of the readmission, the strategy of the Company will change to the New Strategy of "acquiring, managing and operating asset and wealth management activities and interests, together with other related services". The New Strategy will principally focus on making strategic acquisitions and building organic activities in areas of the asset and wealth management sector where the Directors believe structural shifts have the potential to deliver exceptional growth opportunities. This could include strategic acquisitions of undervalued asset and wealth management businesses which have core capabilities that play to these structural shifts, and where active management can unlock value.

 

The Company's headquarters and main country of operation will be the UK.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

6,532,943 ordinary shares of 10p each ("Ordinary Shares").

No restrictions on the transferability of the Ordinary Shares.

 

CAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

The Company's current market capitalisation is approximately £52.3 million, based upon its share price at close of business on 25 March 2021 of 800 pence per Ordinary Share.

 

No capital has been raised on readmission.

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

54.7 per cent

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED:

None

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

Tudor Davies - Chairman, Proposed Non-executive director

Mark Butcher - Non-executive director

Martin Gilbert - Non-executive director, Proposed Chairman

Peter McKellar - Non-executive director, Proposed Deputy Chairman and CEO

Christopher Mills - Non-executive director

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

 

Number of Existing Ordinary Name Shares

Percentage of Existing Share Capital

Harwood Capital Management Limited

1,622,500

24.8%

Toscafund Asset Management LLP

800,000

12.2%

Lombard Odier Asset Management (Europe) Limited

651,500

10.0%

Martin Gilbert

650,000

9.9%

ICM Limited

640,000

9.8%

Richard Griffiths

291,872

4.5%

Peter McKellar

225,000

3.4%

Cadoc Limited

200,000

3.1%

 

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

n/a

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

i. 30 September

ii. 30 September 2020

iii. First three reports:

a. 30 June 2021 (in respect of the half yearly report to 31 March 2021)

b. 31 March 2022 (in respect of the annual report to 30 September 2021)

c. 30 June 2022 (in respect of the half yearly report to 31 March 2022)

 

EXPECTED ADMISSION DATE:

16 April 2021

 

NAME AND ADDRESS OF NOMINATED ADVISER:

Arden Partners plc

125 Old Broad Street, London, EC2N 1AR

 

NAME AND ADDRESS OF BROKER:

Arden Partners plc

125 Old Broad Street, London, EC2N 1AR

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

A copy of the admission document containing full details about the applicant and the admission of its securities is available on the Company's website, www.assetco.com

 

THE CORPORATE GOVERNANCE CODE THE APPLICANT HAS DECIDED TO APPLY

The Company has adopted the Quoted Companies Alliance, Corporate Governance Code, published by the Quoted Companies Alliance

 

DATE OF NOTIFICATION:

31 March 2021

 

NEW/ UPDATE:

New

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PAAEAEDFDEXFEFA
Date   Source Headline
15th Dec 20224:32 pmRNSTransaction in Own Shares
13th Dec 20224:29 pmRNSTransaction in Own Shares
13th Dec 20227:00 amRNSTransaction in Own Shares
7th Dec 20224:25 pmRNSChange of Registered Office
29th Nov 202211:06 amRNSDividend Declaration - Replacement
28th Nov 20224:42 pmRNSHolding(s) in Company
24th Nov 20224:50 pmRNSTransaction in Own Shares
24th Nov 20224:43 pmRNSInterim Dividend Declaration
23rd Nov 20224:47 pmRNSTransaction in Own Shares
22nd Nov 20224:48 pmRNSTransaction in Own Shares
11th Nov 20229:33 amRNSTransaction in Own Shares
9th Nov 20225:54 pmRNSTransaction in Own Shares
9th Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20221:47 pmRNSHolding(s) in Company
1st Nov 20222:56 pmRNSTransaction in Own Shares
1st Nov 20221:25 pmRNSNotification of major holdings
1st Nov 202212:07 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSCompletion of acquisition of SVM Asset Management
31st Oct 20225:36 pmRNSTransaction in Own Shares
27th Oct 202210:23 amRNSHolding(s) in Company
25th Oct 20224:17 pmRNSTransaction in Own Shares
24th Oct 20223:23 pmRNSDirector/PDMR Shareholding
21st Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares
18th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20224:11 pmRNSTransaction in Own Shares
14th Oct 20227:00 amRNSDirector/PDMR Shareholding
12th Oct 20225:04 pmRNSTransaction in Own Shares
12th Oct 20227:00 amRNSAcceleration of £7.5m Share Repurchase Programme
11th Oct 20223:21 pmRNSDirectorate Change
11th Oct 202212:29 pmRNSTransaction in Own Shares
11th Oct 20227:00 amRNSTransaction in Own Shares
7th Oct 20224:19 pmRNSTransaction in Own Shares
6th Oct 20224:26 pmRNSTransaction in Own Shares
5th Oct 20225:13 pmRNSTransaction in Own Shares
4th Oct 20225:43 pmRNSTransaction in Own Shares
3rd Oct 20225:10 pmRNSTransaction in Own Shares
3rd Oct 20224:18 pmRNSDirector/PDMR Shareholding
30th Sep 20225:13 pmRNSTransaction in Own Shares
29th Sep 20226:37 pmRNSTransaction in Own Shares
29th Sep 20227:00 amRNSShare Repurchase Programme & Results of Meeting
12th Sep 20227:00 amRNSDirector/PDMR Shareholding
9th Sep 20227:00 amRNSAuthority to repurchase shares & notice of meeting
8th Sep 20222:05 pmRNSSecond Price Monitoring Extn
8th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSStatement regarding Parmenion Capital Partners LLP
2nd Sep 20223:53 pmRNSTotal Voting Rights
12th Aug 20229:49 amRNSPDMR/PCA Shareholding
10th Aug 202212:45 pmRNSResults of General Meeting
8th Aug 20228:00 amRNSCompletion of the sale of R&M LLC for $8.79m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.